157 related articles for article (PubMed ID: 7833471)
1. Expression of TAL-1 proteins in human tissues.
Pulford K; Lecointe N; Leroy-Viard K; Jones M; Mathieu-Mahul D; Mason DY
Blood; 1995 Feb; 85(3):675-84. PubMed ID: 7833471
[TBL] [Abstract][Full Text] [Related]
2. Expression of tal-1 and GATA-binding proteins during human hematopoiesis.
Mouthon MA; Bernard O; Mitjavila MT; Romeo PH; Vainchenker W; Mathieu-Mahul D
Blood; 1993 Feb; 81(3):647-55. PubMed ID: 7678994
[TBL] [Abstract][Full Text] [Related]
3. Transcription of tal-1, a putative oncogene playing an important role in childhood T-ALL, can be shown in normal peripheral blood cells by a highly sensitive RT-PCR assay.
Anderegg B; Horstmann M; Ernst M; Kabisch H
Pediatr Hematol Oncol; 1997; 14(4):349-58. PubMed ID: 9211539
[TBL] [Abstract][Full Text] [Related]
4. T-cell acute lymphoblastic leukemia--the associated gene SCL/tal codes for a 42-Kd nuclear phosphoprotein.
Goldfarb AN; Goueli S; Mickelson D; Greenberg JM
Blood; 1992 Dec; 80(11):2858-66. PubMed ID: 1450410
[TBL] [Abstract][Full Text] [Related]
5. SCL/Tal-1 expression in T-acute lymphoblastic leukemia: an immunohistochemical and genotypic study.
Chetty R; Pulford K; Jones M; Mathieu-Mahul D; Close P; Hussein S; Pallesen G; Ralfkiaer E; Stein H; Gatter K
Hum Pathol; 1995 Sep; 26(9):994-8. PubMed ID: 7672800
[TBL] [Abstract][Full Text] [Related]
6. A third tal-1 promoter is specifically used in human T cell leukemias.
Bernard O; Azogui O; Lecointe N; Mugneret F; Berger R; Larsen CJ; Mathieu-Mahul D
J Exp Med; 1992 Oct; 176(4):919-25. PubMed ID: 1402666
[TBL] [Abstract][Full Text] [Related]
7. RT/PCR detection of SIL-TAL-1 fusion mRNA in Chinese T-cell acute lymphoblastic leukemia (T-ALL).
Huang W; Kuang SQ; Huang QH; Dong S; Zhang T; Gu LJ; Ching LM; Chen SJ; Chang LC; Chen Z
Cancer Genet Cytogenet; 1995 May; 81(1):76-82. PubMed ID: 7773964
[TBL] [Abstract][Full Text] [Related]
8. Distinct DNase-I hypersensitive sites are associated with TAL-1 transcription in erythroid and T-cell lines.
Leroy-Viard K; Vinit MA; Lecointe N; Mathieu-Mahul D; Roméo PH
Blood; 1994 Dec; 84(11):3819-27. PubMed ID: 7949138
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cellular differentiation by the SCL/tal oncoprotein: transcriptional repression by an Id-like mechanism.
Goldfarb AN; Lewandowska K
Blood; 1995 Jan; 85(2):465-71. PubMed ID: 7812000
[TBL] [Abstract][Full Text] [Related]
10. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis.
Kallianpur AR; Jordan JE; Brandt SJ
Blood; 1994 Mar; 83(5):1200-8. PubMed ID: 8118024
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical study of TAL-1 protein expression in leukaemias and lymphomas with a novel monoclonal antibody, 2TL 242.
Chetty R; Pulford K; Jones M; Mathieu-Mahul D; Close P; Hussein S; Pallesen G; Ralfkiaer E; Stein H; Gatter K; Mason D
J Pathol; 1996 Mar; 178(3):311-5. PubMed ID: 8778337
[TBL] [Abstract][Full Text] [Related]
12. Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation.
Hoang T; Paradis E; Brady G; Billia F; Nakahara K; Iscove NN; Kirsch IR
Blood; 1996 Jan; 87(1):102-11. PubMed ID: 8547631
[TBL] [Abstract][Full Text] [Related]
13. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation.
Voronova AF; Lee F
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5952-6. PubMed ID: 8016095
[TBL] [Abstract][Full Text] [Related]
14. TAL1 expression does not occur in the majority of T-ALL blasts.
Delabesse E; Bernard M; Meyer V; Smit L; Pulford K; Cayuela JM; Ritz J; Bourquelot P; Strominger JL; Valensi F; Macintyre EA
Br J Haematol; 1998 Jul; 102(2):449-57. PubMed ID: 9695959
[TBL] [Abstract][Full Text] [Related]
15. Effects of anti-tal-1 oligodeoxynucleotides in T-ALL cell lines.
Anderegg B; Horstmann M; Kabisch H
Cancer Gene Ther; 1997; 4(2):84-90. PubMed ID: 9080116
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia.
Carlotti E; Pettenella F; Amaru R; Slater S; Lister TA; Barbui T; Basso G; Cazzaniga G; Rambaldi A; Biondi A
Br J Haematol; 2002 Sep; 118(4):1011-8. PubMed ID: 12199779
[TBL] [Abstract][Full Text] [Related]
17. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
O'Neil J; Billa M; Oikemus S; Kelliher M
Oncogene; 2001 Jun; 20(29):3897-905. PubMed ID: 11439353
[TBL] [Abstract][Full Text] [Related]
18. Erythroid-specific inhibition of the tal-1 intragenic promoter is due to binding of a repressor to a novel silencer.
Courtes C; Lecointe N; Le Cam L; Baudoin F; Sardet C; Mathieu-Mahul D
J Biol Chem; 2000 Jan; 275(2):949-58. PubMed ID: 10625632
[TBL] [Abstract][Full Text] [Related]
19. Ectopic TAL-1/SCL expression in phenotypically normal or leukemic myeloid precursors: proliferative and antiapoptotic effects coupled with a differentiation blockade.
Condorelli GL; Tocci A; Botta R; Facchiano F; Testa U; Vitelli L; Valtieri M; Croce CM; Peschle C
Mol Cell Biol; 1997 May; 17(5):2954-69. PubMed ID: 9111367
[TBL] [Abstract][Full Text] [Related]
20. tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.
Breit TM; Beishuizen A; Ludwig WD; Mol EJ; Adriaansen HJ; van Wering ER; van Dongen JJ
Leukemia; 1993 Dec; 7(12):2004-11. PubMed ID: 8255100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
